RS

Ravi Sakinala

Active Director Director DIN 08507007
DIN 08507007 First appointment Jul 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Sakinala

Data last updated:

Ravi Sakinala is a Director at Marconix Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals.

DIN 08507007
Primary Designation Director
Industry Chemicals
First Appointment 11 Jul 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jul 20192019Active

Board colleagues of Ravi Sakinala

NameDINCompanyDesignation
Rajitha Vattipally08507008Marconix Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Marconix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ravi Sakinala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Sakinala

Ravi Sakinala currently holds 1 directorship: Marconix Pharmaceuticals Private Limited (Director, since 11 Jul 2019).

Ravi Sakinala was first appointed on 11 Jul 2019 as Director at Marconix Pharmaceuticals Private Limited.

The current boards of Ravi Sakinala's companies include Rajitha Vattipally (Marconix Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available